We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
10 hedge funds and large institutions have $666K invested in Windtree Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
25% more funds holding
Funds holding: 8 → 10 (+2)
0% more ownership
Funds ownership: 0% → 0% (+0%)
62% less capital invested
Capital invested by funds: $1.76M → $666K (-$1.09M)
Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$88.4K |
| 2 |
Millennium Management
New York
|
+$59K |
| 3 |
RWM
Rockwood Wealth Management
New Hope,
Pennsylvania
|
+$29.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$29.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$29.5K |
Top Sellers
| 1 |
KC
Kepos Capital
New York
|
-$188K |
| 2 |
BlackRock
New York
|
-$56K |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1K |
